Adverse Reactions (123)

All reported adverse reactions from the FDA FAERS database, sorted by total report count.

#	Reaction	Total Reports	Drugs Involved
1	FATIGUE	11,561,068	499
2	OFF LABEL USE	10,077,442	500
3	DRUG INEFFECTIVE	9,988,325	500
4	NAUSEA	9,822,201	499
5	PAIN	8,854,826	500
6	DYSPNOEA	8,799,278	499
7	DIARRHOEA	8,555,594	499
8	HEADACHE	8,339,258	499
9	ARTHRALGIA	7,020,968	490
10	VOMITING	6,887,655	497
11	DIZZINESS	6,403,566	491
12	PYREXIA	6,145,506	484
13	PNEUMONIA	6,004,227	498
14	RASH	5,942,908	497
15	ASTHENIA	5,852,679	491
16	MALAISE	5,427,042	498
17	FALL	5,335,583	479
18	DEATH	4,999,372	476
19	PRURITUS	4,846,888	468
20	TOXICITY TO VARIOUS AGENTS	4,246,942	294
21	CONDITION AGGRAVATED	3,236,806	320
22	INFUSION RELATED REACTION	3,176,492	296
23	RHEUMATOID ARTHRITIS	3,059,530	305
24	JOINT SWELLING	2,910,261	309
25	NASOPHARYNGITIS	2,875,256	310
26	WEIGHT INCREASED	2,537,491	294
27	HYPERTENSION	2,510,977	302
28	PAIN IN EXTREMITY	2,401,221	207
29	SINUSITIS	2,353,744	283
30	HYPERSENSITIVITY	2,295,819	284
31	COMPLETED SUICIDE	2,229,822	279
32	WEIGHT DECREASED	2,141,270	188
33	COUGH	2,096,822	186
34	MYOCARDIAL INFARCTION	1,884,360	135
35	CONSTIPATION	1,707,947	174
36	ANAEMIA	1,605,375	144
37	GASTROINTESTINAL HAEMORRHAGE	1,600,979	131
38	HYPOTENSION	1,572,981	151
39	CHEST PAIN	1,555,298	135
40	FLUSHING	1,505,682	131
41	CEREBROVASCULAR ACCIDENT	1,388,670	132
42	ACUTE KIDNEY INJURY	546,196	51
43	CHRONIC KIDNEY DISEASE	466,244	39
44	ALOPECIA	302,488	23
45	DECREASED APPETITE	300,334	45
46	BACK PAIN	286,799	39
47	ABDOMINAL PAIN	277,458	35
48	RENAL FAILURE	272,647	37
49	ABDOMINAL DISCOMFORT	272,471	21
50	DRUG INTERACTION	263,688	34
51	INJECTION SITE PAIN	230,071	11
52	PERIPHERAL SWELLING	195,249	15
53	ARTHROPATHY	177,556	16
54	DRUG HYPERSENSITIVITY	169,733	16
55	DRUG INTOLERANCE	155,324	8
56	INFECTION	117,503	13
57	PLASMA CELL MYELOMA	113,156	8
58	ASTHMA	99,935	6
59	ANXIETY	97,634	12
60	MUSCULOSKELETAL STIFFNESS	93,281	7
61	SWELLING	91,689	10
62	INSOMNIA	90,393	12
63	TREATMENT FAILURE	88,965	6
64	SYSTEMIC LUPUS ERYTHEMATOSUS	88,767	9
65	NEUTROPENIA	87,422	8
66	PEMPHIGUS	79,506	9
67	CONTRAINDICATED PRODUCT ADMINISTERED	78,654	6
68	THROMBOCYTOPENIA	78,127	8
69	GLOSSODYNIA	74,664	9
70	NEUROPATHY PERIPHERAL	69,563	8
71	INJECTION SITE ERYTHEMA	65,681	3
72	FEBRILE NEUTROPENIA	60,843	7
73	GAIT DISTURBANCE	51,440	7
74	DISEASE PROGRESSION	50,842	7
75	SOMNOLENCE	49,990	6
76	PSORIASIS	49,679	2
77	PLATELET COUNT DECREASED	49,606	8
78	FEELING ABNORMAL	49,574	7
79	DEPRESSION	44,837	6
80	PRODUCT USE IN UNAPPROVED INDICATION	42,925	2
81	SEPSIS	41,784	7
82	DERMATITIS ATOPIC	37,675	1
83	BLOOD GLUCOSE INCREASED	35,076	2
84	INJECTION SITE SWELLING	33,594	2
85	INCORRECT DOSE ADMINISTERED	33,191	2
86	ATRIAL FIBRILLATION	32,871	5
87	PRODUCT DOSE OMISSION ISSUE	29,381	2
88	LACTIC ACIDOSIS	28,204	2
89	OEDEMA PERIPHERAL	24,267	3
90	CARDIAC FAILURE	23,187	3
91	CARDIAC FAILURE CONGESTIVE	22,898	3
92	ECZEMA	22,304	1
93	INJECTION SITE PRURITUS	22,089	1
94	DRY SKIN	21,662	1
95	INJECTION SITE REACTION	20,860	1
96	CROHN^S DISEASE	19,602	1
97	ANGIOEDEMA	19,536	3
98	MYALGIA	18,130	2
99	DEVICE ISSUE	17,971	1
100	INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION	16,307	1
101	INJECTION SITE HAEMORRHAGE	16,123	1
102	INJECTION SITE BRUISING	13,721	1
103	MUSCLE SPASMS	13,167	2
104	SKIN EXFOLIATION	12,486	1
105	BLOOD PRESSURE INCREASED	12,443	2
106	HYPOGLYCAEMIA	12,433	2
107	ACCIDENTAL EXPOSURE TO PRODUCT	12,191	1
108	ERYTHEMA	11,817	1
109	WHITE BLOOD CELL COUNT DECREASED	11,645	1
110	DRY EYE	11,640	1
111	TYPE 2 DIABETES MELLITUS	11,242	1
112	PRODUCT USE ISSUE	10,632	1
113	EXPOSURE VIA SKIN CONTACT	10,321	1
114	EYE PRURITUS	8,919	1
115	PRODUCT DOSE OMISSION IN ERROR	8,398	1
116	THERAPEUTIC RESPONSE DECREASED	8,289	1
117	GENERAL PHYSICAL HEALTH DETERIORATION	7,501	1
118	THROMBOSIS	7,453	1
119	FULL BLOOD COUNT DECREASED	7,025	1
120	CONFUSIONAL STATE	6,844	1
121	COVID-19	6,478	1
122	HYPOAESTHESIA	6,231	1
123	RHABDOMYOLYSIS	5,326	1